Cargando…
Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis
BACKGROUND: Immunohistochemical studies of lymphatic vessels have been limited by a lack of specific markers. Recently, the novel D2-40 antibody, which selectively marks endothelium of lymphatic vessels, was released. The aim of our study is to compare lymphatic and blood vessel invasion detected by...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2294134/ https://www.ncbi.nlm.nih.gov/pubmed/18307818 http://dx.doi.org/10.1186/1471-2407-8-64 |
_version_ | 1782152542228054016 |
---|---|
author | Marinho, Vanessa FZ Metze, Konradin Sanches, Fernanda SF Rocha, Gislene FS Gobbi, Helenice |
author_facet | Marinho, Vanessa FZ Metze, Konradin Sanches, Fernanda SF Rocha, Gislene FS Gobbi, Helenice |
author_sort | Marinho, Vanessa FZ |
collection | PubMed |
description | BACKGROUND: Immunohistochemical studies of lymphatic vessels have been limited by a lack of specific markers. Recently, the novel D2-40 antibody, which selectively marks endothelium of lymphatic vessels, was released. The aim of our study is to compare lymphatic and blood vessel invasion detected by hematoxylin and eosin (H&E) versus that detected by immunohistochemistry, relating them with morphologic and molecular prognostic factors. METHODS: We selected 123 cases of invasive mammary carcinomas stratified into three subgroups according to axillary lymph node status: macrometastases, micrometastases, and lymph node negative. Lymphatic (LVI) and blood (BVI) vessel invasion were evaluated by H&E and immunohistochemistry using the D2-40 and CD31 antibodies, and related to histologic tumor type and grade, estrogen and progesterone receptors, E-cadherin, Ki67, p53, and Her2/neu expression. RESULTS: LVI was detected in H&E-stained sections in 17/123 cases (13.8%), and in D2-40 sections in 35/123 cases (28.5%) (Kappa = 0.433). BVI was detected in H&E-stained sections in 5/123 cases (4.1%), and in CD31 stained sections in 19/123 cases (15.4%) (Kappa = 0.198). LVI is positively related to higher histologic grade (p = 0.013), higher Ki67 expression (p = 0.00013), and to the presence of macrometastases (p = 0.002), and inversely related to estrogen (p = 0.0016) and progesterone (p = 0.00017) receptors expression. CONCLUSION: D2-40 is a reliable marker of lymphatic vessels and is a useful tool for lymphatic emboli identification in immunostained sections of breast carcinomas with higher identification rates than H&E. Lymphatic vessel invasion was related to other features (high combined histologic grade, high Ki67 score, negative hormone receptors expression) associated with worse prognosis, probable reflecting a potential for lymphatic metastatic spread and aggressive behavior. |
format | Text |
id | pubmed-2294134 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-22941342008-04-15 Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis Marinho, Vanessa FZ Metze, Konradin Sanches, Fernanda SF Rocha, Gislene FS Gobbi, Helenice BMC Cancer Research Article BACKGROUND: Immunohistochemical studies of lymphatic vessels have been limited by a lack of specific markers. Recently, the novel D2-40 antibody, which selectively marks endothelium of lymphatic vessels, was released. The aim of our study is to compare lymphatic and blood vessel invasion detected by hematoxylin and eosin (H&E) versus that detected by immunohistochemistry, relating them with morphologic and molecular prognostic factors. METHODS: We selected 123 cases of invasive mammary carcinomas stratified into three subgroups according to axillary lymph node status: macrometastases, micrometastases, and lymph node negative. Lymphatic (LVI) and blood (BVI) vessel invasion were evaluated by H&E and immunohistochemistry using the D2-40 and CD31 antibodies, and related to histologic tumor type and grade, estrogen and progesterone receptors, E-cadherin, Ki67, p53, and Her2/neu expression. RESULTS: LVI was detected in H&E-stained sections in 17/123 cases (13.8%), and in D2-40 sections in 35/123 cases (28.5%) (Kappa = 0.433). BVI was detected in H&E-stained sections in 5/123 cases (4.1%), and in CD31 stained sections in 19/123 cases (15.4%) (Kappa = 0.198). LVI is positively related to higher histologic grade (p = 0.013), higher Ki67 expression (p = 0.00013), and to the presence of macrometastases (p = 0.002), and inversely related to estrogen (p = 0.0016) and progesterone (p = 0.00017) receptors expression. CONCLUSION: D2-40 is a reliable marker of lymphatic vessels and is a useful tool for lymphatic emboli identification in immunostained sections of breast carcinomas with higher identification rates than H&E. Lymphatic vessel invasion was related to other features (high combined histologic grade, high Ki67 score, negative hormone receptors expression) associated with worse prognosis, probable reflecting a potential for lymphatic metastatic spread and aggressive behavior. BioMed Central 2008-02-29 /pmc/articles/PMC2294134/ /pubmed/18307818 http://dx.doi.org/10.1186/1471-2407-8-64 Text en Copyright © 2008 Marinho et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Marinho, Vanessa FZ Metze, Konradin Sanches, Fernanda SF Rocha, Gislene FS Gobbi, Helenice Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis |
title | Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis |
title_full | Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis |
title_fullStr | Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis |
title_full_unstemmed | Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis |
title_short | Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis |
title_sort | lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker d2-40 is associated with other indicators of poor prognosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2294134/ https://www.ncbi.nlm.nih.gov/pubmed/18307818 http://dx.doi.org/10.1186/1471-2407-8-64 |
work_keys_str_mv | AT marinhovanessafz lymphvascularinvasionininvasivemammarycarcinomasidentifiedbytheendotheliallymphaticmarkerd240isassociatedwithotherindicatorsofpoorprognosis AT metzekonradin lymphvascularinvasionininvasivemammarycarcinomasidentifiedbytheendotheliallymphaticmarkerd240isassociatedwithotherindicatorsofpoorprognosis AT sanchesfernandasf lymphvascularinvasionininvasivemammarycarcinomasidentifiedbytheendotheliallymphaticmarkerd240isassociatedwithotherindicatorsofpoorprognosis AT rochagislenefs lymphvascularinvasionininvasivemammarycarcinomasidentifiedbytheendotheliallymphaticmarkerd240isassociatedwithotherindicatorsofpoorprognosis AT gobbihelenice lymphvascularinvasionininvasivemammarycarcinomasidentifiedbytheendotheliallymphaticmarkerd240isassociatedwithotherindicatorsofpoorprognosis |